StuartHIsaacsonMDFAAN

Movement Disorder

Associate Professor of Neurology at the Florida International University Herbert Wertheim College of Medicine in Miami Director and Founder Parkinson's Disease and Movement Disorders Center of Boca Raton

Join to view full profile

Dr. Isaacson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Isaacson's full profile

Already have an account?

Office
Parkinson’s Disease and Movement Disorders Center of Boca Raton
951 Nw 13th St, Bldg 5-E
Boca Raton, FL 33486
Phone+1 561-392-1818

Fax+1 561-392-8989
Is this information wrong?

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Neuromuscular Medicine (Neurology), 1995 - 1996
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 1989 - 1992
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1988 - 1989
Northwestern University The Feinberg School of MedicineClass of 1988

Certifications & Licensure

FL State Medical License 1997 - 2026
NY State Medical License 1989 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014-2019
Super Doctor SuperDoctors.com

Clinical Trials

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
Completed
Phase 2
A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study Start of enrollment: 2013 Feb 01
Completed
Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) Start of enrollment: 2012 Dec 01
Completed
Phase 4
A Study to Examine APL-130277 in Patients With Parkinson's Disease Start of enrollment: 2014 Aug 31
Completed
Phase 2
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation Start of enrollment: 2017 May 11
Completed
Phase 1, Phase 2
The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease Start of enrollment: 2017 Apr 30
Completed
Not Applicable
A Phase 3 Study With P2B001 in Subjects With Early Parkinson's Start of enrollment: 2018 Jan 19
Completed
Phase 3
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide) Start of enrollment: 2017 Nov 30
Completed
Fixed-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2019 Dec 13
Active, not recruiting
Phase 3
Roles: Contact
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations Start of enrollment: 2020 Oct 27
Active, not recruiting
Phase 3
Open-label Trial in Parkinson's Disease (PD) Start of enrollment: 2021 Feb 24
Enrolling by invitation
Phase 3
Roles: Contact
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 Start of enrollment: 2016 Jul 01
Unknown status
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study.
Jan Kassubek, Ernest Balaguer, Johannes Schwarz, K Ray Chaudhuri, Stacy Wu, Carmen Denecke Muhr, Jaime Kulisevsky, Stewart A Factor, Stuart H Isaacson> ;Journal of Neurology. 2024 Mar 28
1 citations
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised,...
Alberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, Alberto Albanese, Aaron Ellenbogen, Joaquim J Ferreira, Nir Giladi, Tanya Gurevich, Sharon Hassin-Baer, Jorge Hernande...> ;The Lancet. Neurology. 2024 Mar 15
Hope vs. Hype III: Rescue/on-demand therapies are preferable to device-assisted therapies in Parkinson disease.
Stuart Isaacson, Oliver Phillips, Joohi Jimenez-Shahed> ;Parkinsonism & Related Disorders. 2024 Mar 3
2 citations
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial.
Robert A Hauser, Alberto J Espay, Aaron L Ellenbogen, Hubert H Fernandez, Stuart H Isaacson, Peter A LeWitt, William G Ondo, Rajesh Pahwa, Johannes Schwarz, Fabrizio S...> ;JAMA Neurology. 2023 Oct 1
1 citations
Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease.
Stuart H Isaacson, Daniel Kremens, Yasar Torres-Yaghi, Fabrizio Stocchi, Angelo Antonini> ;Parkinsonism & Related Disorders. 2023 Sep 1
Correction to: Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.
Rajesh Pahwa, Stuart H Isaacson, Gary W Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh> ;Neurology and Therapy. 2023 Oct 1
2 citations
Expert Consensus on the Use of-Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel.
Stuart H Isaacson, Madhureeta Achari, Roongroj Bhidayasiri, Cynthia Comella, Jill Giordano Farmer, Fiona Gupta, Sarah Jones, David Kreitzman, Daniel Kremens, Simon J G...> ;Movement Disorders Clinical Practice. 2023 Apr 1
Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson's disease.
Bruno Bergmans, Veronica Clark, Tobias Bäumer, Isaacson, S.> ;Clinical Parkinsonism & Related Disorders. 2023 Jan 1
1 citations
Feasibility of home dose optimization of apomorphine sublingual film in Parkinson's disease patients with OFF episodes: results from the dose-optimization phase of an ...
Jan Kassubek, Fabrizio Stocchi, Ernest Balaguer Martinez, Rajesh Pahwa, William Ondo, Yi Zhang, Alyssa Bowling, Eric Pappert, Stuart Isaacson, Stacy Wu> ;Therapeutic Advances in Neurological Disorders. 2023 Jan 1
Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson's Disease.
Salima Brillman, Pravin Khemani, Stuart H Isaacson, Rajesh Pahwa, Ruta Deshpande, Vivien Zraick, Apoorva Rajagopal, Dhira Khosla, Kathryn H Rosenbluth> ;Tremor and Other Hyperkinetic Movements. 2023 Jan 1
3 citations
Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment.
Stuart H Isaacson, Robert A Hauser, Rajesh Pahwa, David Gray, Sridhar Duvvuri> ;Clinical Parkinsonism & Related Disorders. 2023 Jan 1
2 citations
How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature.
Stuart H Isaacson, Richard B Dewey Jr, Rajesh Pahwa, Daniel E Kremens> ;Clinical Parkinsonism & Related Disorders. 2023 Jan 1
Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson's disease: Post-hoc analyses from a large 54-week trial.
Rajesh Pahwa, Jason Aldred, Aristide Merola, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R Steffen, Prasanna L Kandukuri, Yanjun Bao, Omar Ladhani, Conni...> ;Clinical Parkinsonism & Related Disorders. 2023 Jan 1
1 citations
Motor response with apomorphine sublingual film and levodopa in patients with OFF episodes.
Stuart H Isaacson, Alyssa Bowling, Ian Zhang, Eric Pappert, Fabrizio Stocchi> ;Neurodegenerative Disease Management. 2023 Apr 1
Frequency of non-motor symptoms in Parkinson's disease patients carrying the E326K and T369M GBA risk variants.
Tatiana Usnich, Maria Olmedillas, Nathalie Schell, Jefri J Paul, Filipa Curado, Snezana Skobalj, Ilona Csoti, Sibel Ertan, Doreen Gruber, Simone Zittel, Esther Sammler...> ;Parkinsonism & Related Disorders. 2023 Feb 1
11 citations
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-anal...
Angelo Antonini, Rajesh Pahwa, Per Odin, Stuart H Isaacson, Aristide Merola, Lin Wang, Prasanna L Kandukuri, Ali Alobaidi, Connie H Yan, Yanjun Bao, Cindy Zadikoff, Ju...> ;CNS Drugs. 2022 Dec 1
2 citations
Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia.
Richard Jackson, Matthew N Brams, Noelle E Carlozzi, Leslie Citrome, Nora E Fritz, Amber R Hoberg, Stuart H Isaacson, John M Kane, Rajeev Kumar> ;The Journal of Clinical Psychiatry. 2022 Nov 28
2 citations
Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.
Rajesh Pahwa, Stuart H Isaacson, Gary W Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh> ;Neurology and Therapy. 2022 Dec 1
7 citations
Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directions.
Stuart H Isaacson, Leslie Citrome> ;Expert Opinion on Drug Safety. 2022 Jul 1
1 citations
Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Tri...
Rajesh Pahwa, Jason Aldred, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R Steffen, Prasanna L Kandukuri, Vivek S Chaudhari, Yash J Jalundhwala, Yanjun Ba...> ;Neurology and Therapy. 2022 Jun 1
1 citations
Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis.
Marwan Sabbagh, Gary W Small, Stuart H Isaacson, Yasar Torres-Yaghi, Fernando Pagan, Rajesh Pahwa> ;International Journal of Psychiatry in Clinical Practice. 2023 Mar 1
Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic.
Shadi Ghourchian, Yasar A Torres-Yaghi, Stuart H Isaacson, Fernando Pagan, Kelly E Lyons, Brian James Nagle, Sanskruti Patel, Rajesh Pahwa> ;Telemedicine Journal and e-Health. 2022 Mar 17
3 citations
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment.
Robert A Hauser, Antonella Favit, L Arthur Hewitt, Annika Lindsten, Stephen Gorny, Steven Kymes, Stuart H Isaacson> ;Neurology and Therapy. 2022 Mar 1
4 citations
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 Countries.
Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J Soileau, Ramon Rodriguez-Cruz, Stuart H Isaacson, Aristide Merola, Susanna Lindvall, Josefa Domingos...> ;Neurology and Therapy. 2022 Mar 1
5 citations
Evaluation of morning bradykinesia in Parkinson's disease in a United States cohort using continuous objective monitoring.
S H Isaacson, R Pahwa, E J Pappert, D Torres-Russotto> ;Clinical Parkinsonism & Related Disorders. 2022 Jan 1
Join now to see all

Press Mentions

BeyoND Phase 2b Data Indicates ND0612 Has a Positive Long-Term Safety Profile for People with Parkinson's DiseaseApril 4th, 2022
Cala Health Receives FDA Breakthrough Device Designation for Cala Trio™ Therapy to Treat Action Tremors in Parkinson's DiseaseOctober 22nd, 2020
Daily Use of Cala Trio Device Effectively Eases Hand Tremors, Trial ReportsSeptember 30th, 2019
Join now to see all